{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:13:44Z","timestamp":1791764024763,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.oret.2025.03.001","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T20:48:24Z","timestamp":1741639704000},"page":"870-882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk and Dose\u2013Response Relationship for Pentosan Polysulfate Sodium Maculopathy"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7069-3162","authenticated-orcid":false,"given":"Brendan K.","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korolos","family":"Sawires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanansayan","family":"Dhivagaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudra Rishi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2025.03.001_bib1","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ophtha.2018.04.026","article-title":"Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium","volume":"125","author":"Pearce","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.001_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.survophthal.2021.05.005","article-title":"Pentosan polysulfate maculopathy","volume":"67","author":"Lindeke-Myers","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.001_bib3","series-title":"Pentosan Polysulfate Maculopathy","author":"Margines","year":"2024"},{"key":"10.1016\/j.oret.2025.03.001_bib4","series-title":"Elmiron Product Monograph","year":"2008"},{"key":"10.1016\/j.oret.2025.03.001_bib5","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaophthalmol.2019.3392","article-title":"Phenotypic spectrum of pentosan polysulfate sodium-associated maculopathy: a multicenter study","volume":"137","author":"Hanif","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.001_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajo.2021.02.025","article-title":"Pentosan polysulfate maculopathy: prevalence, spectrum of disease, and choroidal imaging analysis based on prospective screening","volume":"227","author":"Wang","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.001_bib7","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ophtha.2019.04.024","article-title":"Strength of association between pentosan polysulfate and a novel maculopathy","volume":"126","author":"Hanif","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.001_bib8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ophtha.2020.01.017","article-title":"Prevalence of maculopathy associated with long-term pentosan polysulfate therapy","volume":"127","author":"Vora","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.001_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcjo.2019.12.001","article-title":"Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis","volume":"55","author":"Wang","year":"2020","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.001_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8866961","article-title":"Identification of patients with pentosan polysulfate sodium-associated maculopathy through screening of the electronic medical record at an academic center","volume":"2020","author":"Higgins","year":"2020","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.001_bib11","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/IAE.0000000000003078","article-title":"Pentosan polysulfate and vision: findings from an international survey of exposed individuals","volume":"41","author":"Uner","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.03.001_bib12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/bjophthalmol-2019-314765","article-title":"Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort","volume":"104","author":"Jain","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.001_bib13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ophtha.2019.10.036","article-title":"Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States","volume":"127","author":"Ludwig","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.001_bib14","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1111\/bcp.15303","article-title":"Risk of maculopathy with pentosan polysulfate sodium use","volume":"88","author":"Bae","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.oret.2025.03.001_bib15","article-title":"Evolution of pentosan polysulfate maculopathy following medication discontinuation","author":"Ka-Lok Tao","year":"2024","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.oret.2025.03.001_bib16","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/IAE.0000000000003844","article-title":"Refining the retinal phenotype of patients with suspected pentosan polysulfate sodium retinopathy","volume":"43","author":"Kalaw","year":"2023","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.03.001_bib17","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.5","year":"2024"},{"key":"10.1016\/j.oret.2025.03.001_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.oret.2025.03.001_bib19","article-title":"Screening practices and risk assessment for maculopathy in pentosan polysulfate users across different exposure levels","volume":"14","author":"Kwon","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2025.03.001_bib20","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.2147\/OPTH.S340041","article-title":"Pentosan polysulfate sodium-associated pigmentary retinopathy: risk factors and fundus findings","volume":"15","author":"Leung","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.001_bib21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/09286586.2022.2031227","article-title":"Prevalence and dose dependency analysis of pentosan polysulfate sodium maculopathy","volume":"30","author":"Philip","year":"2023","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.oret.2025.03.001_bib22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.oret.2022.03.016","article-title":"Redefining the spectrum of pentosan polysulfate retinopathy: multimodal imaging findings from a cross-sectional screening study","volume":"6","author":"Dieu","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2025.03.001_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.oret.2021.07.004","article-title":"Expanded clinical spectrum of pentosan polysulfate maculopathy: a Macula Society Collaborative Study","volume":"6","author":"Jain","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2025.03.001_bib24","author":"Soto"},{"key":"10.1016\/j.oret.2025.03.001_bib25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0022-5347(17)43241-1","article-title":"A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease","volume":"138","author":"Holm-Bentzen","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.oret.2025.03.001_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0090-4295(97)00110-6","article-title":"Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: a meta-analysis","volume":"50","author":"Hwang","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.oret.2025.03.001_bib27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0090-4295(90)80116-5","article-title":"Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study","volume":"35","author":"Mulholland","year":"1990","journal-title":"Urology"},{"key":"10.1016\/j.oret.2025.03.001_bib28","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.urology.2004.10.071","article-title":"Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis","volume":"65","author":"Nickel","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.oret.2025.03.001_bib29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0022-5347(17)35629-X","article-title":"A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate","volume":"150","author":"Parsons","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.oret.2025.03.001_bib30","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.juro.2014.09.036","article-title":"Pentosan polysulfate sodium for treatment of interstitial cystitis\/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study","volume":"193","author":"Nickel","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.oret.2025.03.001_bib31","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/01.ju.0000083020.06212.3d","article-title":"A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis","volume":"170","author":"Sant","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.oret.2025.03.001_bib32","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1080\/03007995.2019.1586401","article-title":"Efficacy of pentosan polysulfate for the treatment of interstitial cystitis\/bladder pain syndrome: results of a systematic review of randomized controlled trials","volume":"35","author":"van Ophoven","year":"2019","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.oret.2025.03.001_bib34","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ophtha.2018.12.037","article-title":"Re: Pearce et al.: Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium (Ophthalmology. 2018;125:1793\u20131802)","volume":"126","author":"Greenlee","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.001_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000519275","article-title":"Reversible retinopathy associated with fibroblast growth factor receptor inhibitor","volume":"13","author":"Patel","year":"2022","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.001_bib36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2147\/OPTH.S285013","article-title":"Maculopathy secondary to pentosan polysulfate use: a single-center experience","volume":"15","author":"Kalbag","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.001_bib37","first-page":"11732","article-title":"Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation?","volume":"30","author":"Proctor","year":"2023","journal-title":"Can J Urol"},{"key":"10.1016\/j.oret.2025.03.001_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jamaophthalmol.2021.4778","article-title":"Association between pentosan polysulfate sodium and retinal disorders","volume":"140","author":"McGwin","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.001_bib39","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025000983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025000983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:51:27Z","timestamp":1768312287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653025000983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2468653025000983"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2025.03.001","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk and Dose\u2013Response Relationship for Pentosan Polysulfate Sodium Maculopathy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2025.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00c2\u00a9 2025 Published by Elsevier Inc. on behalf of American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}